SEARCH
Current Location:
>
> This Story

starstarstarstarempty star (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

The global proton therapy market will hit $1 billion by 2019 Clinical evidence and compact proton therapy systems fuel growth

Ultrasound with contrast for pediatrics with abdominal trauma superior to CT British study results indicate new lower radiation dose protocol for kids

St. Jude Medical completes acquisition of Spinal Modulation, Inc. Axium Neurostimulator system is seeking FDA approval

Welch Allyn acquires Scale-Tronix Broadens portfolio by adding medical scales to physical assessment product line

Antibiotic resistance: 'A natural feature of most bacteria' Resistance genes present in the microbiomes of remote tribespeople

SPECT can help physicians differentiate between PTSD and Traumatic Brain Injuries: study Success of new TBI treatment relies on SPECT information

Telehealth program cuts costs by 27 percent for Banner Health Reduces hospitalization among chronically ill by 45 percent

Oxford Instruments acquires Medical Imaging Resources for $24 million Deal expands Oxford's imaging footprint with a mobile medical expertise

Apple Watch, the newest diagnostic tool in the battle against chronic diseases? A pilot program from Ochsner Health System thinks it could be

Royal Philips launches its 3-D navigation system, VesselNavigator Provides guidance for minimally invasive treatment of vascular disease

Breast tomosynthesis on verge of U.S. approval, but questions linger

by Brendon Nafziger , DOTmed News Associate Editor
By Brendon Nafziger and Olga Deshchenko, DOTmed News Reporters

Hologic Inc.'s breast tomosynthesis device received near-final U.S. Food and Drug Administration approval, and is poised to become the first such device to be sold in America.

Story Continues Below Advertisement

Transform the power of imaging equipment into tangible clinical benefits

Siemens Imaging software makes reading, storing & sharing clinical images easier & more efficient by providing a common user interface across all modalities to streamline the technologist and radiologist workflow. Read more>



The 3-D breast scanning technology aims to improve detection of cancer by revealing cancerous masses hidden by overlying breast tissue, but some experts say not enough published data exists to determine how useful the technology will be.

Plus, there are concerns about how it will fit into existing workflows.

"We do have a responsibility to be very careful when we're introducing new technologies, that we have the data to support that it is better for patients," said Dr. Wendie Berg, a breast imaging consultant with the American College of Radiology Imaging Network in Maryland.

Bedford, Mass.-based Hologic said Tuesday it received an "approvable" letter for the Selenia Dimensions 3-D digital mammography system from the FDA. This means final approval will come once the agency makes sure the company's manufacturing plant is up to snuff.

The technology is already available in Europe from Hologic and other manufacturers, including Siemens Healthcare. It works by spinning around the breast in an arc and taking multiple snapshots, then reconstructing all the slices into a 3-D image.

Proponents of the technology tout improvements over 2-D digital mammography in detecting cancerous masses in breasts that could be obscured by overlapping breast tissue.

"Because you can, in effect, see through tissues on top of other structures, that makes it easier to see the edges of masses," Berg said. She said based on data presented by Massachusetts General Hospital, but never published, the technology could improve cancer detection by about 10 percent.

Also, the hope is that the technology could reduce the recall rate - that is, the number of women called back for a follow-up exam based on ambiguous findings.

Berg said recall rates vary by doctors, centers and patient populations, but early research suggests with tomosynthesis the rate could fall from about 10 percent to around 6 percent. "It's an important decrease," she said, as the harms due to false positives were one of the issues raised by a controversial government task force on mammography last year.

Dr. Martine Backenstoss, section chief of mammography with Rochester General Hospital in New York, hopes 3-D technology enables radiologists to forego spot compression imaging because it displays the breasts in slices.

Continue reading Breast tomosynthesis on verge of U.S. approval, but questions linger...
  Pages: 1 - 2 - 3 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED